Skip to main content
Clinical Trials/CTRI/2023/10/058408
CTRI/2023/10/058408Not yet recruitingPhase 2

Clinical Efficacy of Chirabilva(Holoptelea Integrifolia)leaf extract in Dantshula(tooth ache) caused due to KrimiDant (Dental carries): A prospective single arm study. - Nil

Maharashtra University of Health Sciences Nashik0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 2
Status
Not yet recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • Patients of either sex in the age group of 18 to 60 yrs.
  • Patients of tooth ache due to dental carries.

Exclusion Criteria

  • Patients with systemic disorders e.g.uncontrolled diabetes, renal disorders.
  • Other diseases of oral cavity e.g.fractured tooth, periodontal abscess,oral cancers.
  • Patients with dental carries but not willing to participate in the trial.
  • Known Hypersensitivity to any drug or herbal product.
  • Congenital deformity of teeth (hypomineralization of the tooth and hypoplasia of the tooth.)
  • History of psychiatric disorders.

Investigators

Sponsor
Maharashtra University of Health Sciences Nashik

Similar Trials